SHENELLE PAULSON: Open Payments
NPI 1083108500 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,887 in 92 payments from 16 companies in 2025. Trend: 2023 $1,130 · 2024 $1,868 · 2025 $1,887
Food & beverage: $1,887
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $474 |
| Janssen Biotech, Inc. | 13 | $340 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $165 |
| GENZYME CORPORATION | 6 | $150 |
| QOL Medical, LLC | 6 | $137 |
| Gilead Sciences, Inc. | 5 | $124 |
| Aimmune Therapeutics, Inc. | 5 | $122 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $79 |
| Phathom Pharmaceuticals, Inc. | 2 | $73 |
| Ipsen Biopharmaceuticals, Inc | 3 | $61 |
Products named: TREMFYA, DUPIXENT, RINVOQ, Sucraid, CREON, ZENPEP, ENTYVIO, SKYRIZI.
Industry payments across FL — which companies pay providers there.
